TrademarkDir
GENESIS THERAPEUTICS
LIVE

Serial Number

97259016

Owner

Genesis Therapeutics, Inc.

Attorney

EMILIA F. CANNELLA

Filing Date

Feb 9, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GENESIS THERAPEUTICS Trademark

Serial Number: 97259016

GENESIS THERAPEUTICS is a trademark filed by Genesis Therapeutics, Inc. on February 9, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Genesis Therapeutics, Inc.

1860 El Camino Real, Suite #400
Burlingame, CA 940103117

Entity Type: 03

GENESIS MOLECULAR AI, INC.

1440 CHAPIN AVE, SUITE #385
BURLINGAME, CA 94010

Entity Type: 03

Trademark Details

Filing Date

February 9, 2022

Registration Date

Not Registered

Published for Opposition

July 2, 2024

Goods & Services

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of rare autoimmune and immune-system-related diseases and disorders; all of the foregoing excluding preparations for the treatment of ocular and opthalmic diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 23, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jun 22, 2026 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 18, 2026 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 11, 2026 ASGN
SOU TEAS EXTENSION RECEIVED
Feb 5, 2026 EEXT
SOU EXTENSION 3 FILED
Feb 4, 2026 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 13, 2025 EX2G
SOU EXTENSION 2 FILED
Aug 13, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2025 EXRA
SOU EXTENSION 1 GRANTED
Feb 6, 2025 EX1G
SOU EXTENSION 1 FILED
Feb 6, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 6, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 27, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 12, 2024 NONP
EXPARTE APPEAL TERMINATED
May 28, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 24, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
May 24, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 24, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 24, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 27, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 27, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 27, 2023 GNFN
FINAL REFUSAL E-MAILED
Nov 27, 2023 GNFR
FINAL REFUSAL WRITTEN
Nov 27, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 9, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 9, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 23, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 22, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2022 NWOS
NEW APPLICATION ENTERED
Feb 12, 2022 NWAP

Related Trademarks